Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsisRajesh K. Thimmulappa(Johns Hopkins University)Journal of Clinical InvestigationMarch 23, 200610.1172/jci25790Cited by 1,035SaveCiteExport RISWatch citationsRelated PapersNRF2 signaling is repressed in HPV-driven head and neck cancer and correlates with better prognosis: HPV-E6/E7 confers chemosensitivity by inhibiting NRF2|Research Square|2022|1Human Papillomavirus-driven repression of NRF2 signaling confers chemosensitivity and predicts prognosis in head and neck squamous cell carcinoma|Research Square|2022|0